Continuous Glucose Monitoring Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 7.5 billion
Estimated Base Value
2035 Forecast
US$ 18.8 billion
Projected Market Value
CAGR 2026–2035
9.6%
Compound Annual Growth
Largest Segment
Real-Time Continuous Glucose Monitoring Systems
Fastest Growing Segment
Implantable Continuous Glucose Monitoring Systems
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
48.0% market share
Key Players
DexCom
Emerging Players
Indigo Diabetes, Medtrum Technologies
Market Definition & Overview
The Continuous Glucose Monitoring (CGM) market encompasses advanced medical devices and integrated systems designed for real-time, continuous measurement of glucose levels in interstitial fluid, providing actionable data for diabetes management. Operating within the broader Remote Patient Monitoring industry, CGM technology typically consists of a disposable sensor, a reusable transmitter, and a receiver (either a dedicated device or a smartphone application) that wirelessly relay glucose readings. These systems enable individuals with diabetes, their caregivers, and healthcare professionals to monitor glucose trends, identify hypoglycemia and hyperglycemia, and optimize treatment regimens without frequent finger-prick tests, thereby improving glycemic control and quality of life through continuous oversight.
Scope
- Global market coverage across all major regions
- Analysis by product type (sensors, transmitters, receivers, software)
- Segmentation by end-user (e.g., home care settings, hospitals, clinics)
- Market forecast period typically spanning ten years (e.g., 2023-2033)
Inclusions
- CGM sensors (disposable components worn by the user)
- CGM transmitters (reusable devices that send data from the sensor)
- CGM receivers (dedicated handheld display units or smart device applications)
- Software and cloud-based platforms for CGM data management and analysis
- Integrated insulin pump systems with embedded CGM functionality
- Subscription services for data sharing and remote monitoring platforms
Exclusions
- Traditional Blood Glucose Meters (BGMs) and associated test strips
- Insulin pumps without integrated CGM capabilities
- Hospital-based point-of-care glucose testing equipment
- Non-invasive glucose monitoring research and development
- Wearable devices solely for general fitness tracking without medical glucose sensing
Market Size Forecast
Executive Summary
• The Continuous Glucose Monitoring market is valued at $7.5 Bn in 2025 and is forecast to reach $18.8 Bn by 2035, reflecting a robust CAGR of 9.6% as demand accelerates across every major segment and region over the ten-year outlook.
• Real-Time Continuous Glucose Monitoring Systems leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 14.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 48.0% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying competitive dynamics manifest in strategic acquisitions and robust R&D, consolidating leadership among top-tier players while fueling innovation in sensor accuracy and data integration for global market dominance.
• Expanding payer coverage and evolving clinical guidelines are crucial catalysts, propelling CGM adoption beyond intensive insulin management into broader Type 2 non-insulin populations and preventative health across key global regions.
• Technological advancements, including extended wear times, enhanced accuracy, and AI-driven predictive analytics, are transforming patient experience and clinical utility, bolstering adherence and driving demand across diverse global demographic segments.
• Favorable regulatory pathways and expanding reimbursement policies, particularly in key developed markets, are critical enablers, accelerating market penetration and accessibility while stimulating product diversification and regional strategic investment.
• Emerging market penetration represents a critical long-term strategic imperative, with direct-to-consumer models and simplified access points poised to unlock significant growth beyond traditional healthcare channels and segments.
• Strategic supply chain resilience and sustained venture capital investment in integrated digital health platforms are pivotal for sustaining rapid market expansion and fostering next-generation connected care ecosystems globally.
Key Market Takeaways
Critical findings and data points from this market research study.
Base Year Valuation
The Continuous Glucose Monitoring market was valued at $7.5 billion in the base year, highlighting its established presence in remote patient monitoring.
Robust Growth Outlook
The market is projected to reach $18.8 billion by the forecast year, demonstrating significant potential for expansion.
Steady Growth Trajectory
A Compound Annual Growth Rate (CAGR) of 9.6% indicates a consistent and healthy upward trend for the CGM market.
North America Leadership
North America is expected to be the leading region in the CGM market, driven by high diabetes prevalence and advanced healthcare infrastructure.
Expanding User Adoption
A notable trend is the increasing adoption of CGM devices beyond Type 1 diabetes patients to include Type 2 diabetics and even non-diabetic individuals for health monitoring.
Significant Market Opportunity
These figures collectively underscore a substantial and growing market opportunity for Continuous Glucose Monitoring technologies within the medical device industry.
Market Dynamics
Market Trends
- Real-time CGM adoption is rapidly increasing among users.
- Integration with smart devices and digital health platforms grows.
- Focus on non-invasive and minimally invasive technologies continues.
- Expansion into Type 2 diabetes and pre-diabetic monitoring accelerates.
Growth Drivers
- Global prevalence of diabetes fuels demand for CGM devices.
- Growing awareness promotes proactive glucose management solutions.
- Technological advancements improve sensor accuracy and user experience.
- Favorable reimbursement policies encourage market growth.
Restraints
- High device cost and limited insurance reimbursement hinder broader adoption.
- User discomfort and potential skin irritation from prolonged sensor wear.
- Need for calibration and occasional accuracy concerns impact user trust.
- Data interpretation challenges for users without professional guidance.
Opportunities
- Untapped markets in developing regions offer significant growth.
- Personalized healthcare and predictive analytics integration is key.
- Expansion to non-diabetic populations for wellness monitoring.
- Developing implantable and long-term CGM solutions.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Real-Time Continuous Glucose Monitoring SystemsIntermittently Scanned Continuous Glucose Monitoring SystemsImplantable Continuous Glucose Monitoring Systems |
| By Component | SensorsTransmittersReceivers & DisplaysSoftware & Mobile Applications |
| By Connectivity Technology | Bluetooth Low EnergyNear Field CommunicationProprietary RF Communication |
| By Application | Type 1 Diabetes ManagementType 2 Diabetes ManagementPrediabetes & General Health and Wellness |
| By End User | Hospitals & Critical CareSpecialty Clinics & Physician OfficesHome Care Settings |
| By Distribution Channel | Hospital PharmaciesRetail Pharmacies & Drug StoresOnline ChannelsMedical Device Distributors |
Regional Analysis
- North America leads the CGM market due to its high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of innovative medical technologies. Favorable reimbursement policies and significant R&D investments further bolster its dominant position in remote patient monitoring.
- Asia-Pacific is projected to be the fastest-growing region, driven by its large and expanding diabetic population and increasing healthcare expenditure. Growing awareness about diabetes management, coupled with improving healthcare infrastructure, fuels the rapid adoption of CGM devices here.
- In Europe, a notable trend is the increasing push for broader integration of CGM devices with digital health platforms and telemedicine services. This aims to enhance patient accessibility and improve data-driven diabetes management across various healthcare systems, emphasizing cost-effectiveness.
Asia Pacific
12.5% CAGR
$1.5 Bn
20% share
- Rapidly growing market propelled by a large and aging population, increasing diabetes burden, improving healthcare access, and rising disposable incomes fueling technology adoption.
North America
9.5% CAGR
$2.6 Bn
35% share
- Dominant market share driven by high diabetes prevalence, advanced healthcare infrastructure, strong reimbursement policies, and early adoption of innovative CGM technologies.
Europe
9.0% CAGR
$2.1 Bn
28% share
- Significant market due to increasing diabetes incidence, supportive government initiatives, and rising awareness about the benefits of continuous glucose monitoring for better disease management.
Latin America
11.0% CAGR
$600.0 Mn
8% share
- Emerging market with substantial growth potential, driven by increasing diabetes awareness and improving healthcare infrastructure, though still facing challenges in affordability and widespread access.
Middle East & Africa
10.0% CAGR
$450.0 Mn
6% share
- Growing market influenced by high diabetes prevalence in certain regions and expanding healthcare investments, though market penetration remains varied across different countries.
Emerging Areas
14.0% CAGR
$225.0 Mn
3% share
- Niche but high-growth segment representing nascent geographies with low current penetration, expected to expand rapidly as healthcare infrastructure improves and awareness increases.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $3.6 Bn | 9.5% | As the largest and most mature market, the U.S. benefits from high diabetes prevalence, strong patient awareness, and favorable reimbursement policies for advanced CGM technologies. It remains a hub for innovation and rapid adoption of new devices. |
| 2 | Brazil | $390.0 Mn | 15.0% | The largest country in South America, Brazil faces a substantial diabetes burden, fueling demand for effective management tools like CGM. Improving healthcare infrastructure and rising disposable income contribute to market expansion. |
| 3 | Germany | $577.5 Mn | 10.0% | As Europe's largest economy, Germany leads in CGM adoption due to its robust healthcare system, high healthcare spending, and strong patient demand for advanced diabetes management. Favorable reimbursement policies further support market growth. |
| 4 | China | $577.5 Mn | 20.0% | With the world's largest diabetic population and a rapidly expanding healthcare market, China is a critical growth engine for CGM. Strong government support for domestic innovation and digital health solutions is accelerating adoption. |
| 5 | Saudi Arabia | $112.5 Mn | 16.0% | Saudi Arabia has one of the highest diabetes prevalence rates globally, coupled with substantial government investment in healthcare, driving rapid adoption of advanced CGM technologies. |
Countries Covered (24)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, Australia, South Korea, India, Taiwan, Indonesia, Rest of Asia Pacific, Saudi Arabia, UAE, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | DexCom | 5.7% | Focus on innovation and expanding market access for real-time CGM systems, including integration with insulin pumps and digital health solutions. | One of the global leaders in real-time continuous glucose monitoring, widely adopted for both type 1 and type 2 diabetes management. | Recently launched Dexcom G7 globally, offering a smaller, all-in-one sensor with a shorter warm-up time. | Dexcom G7Dexcom G6Dexcom G5 Mobile+1 |
| 2 | Senseonics Holdings, Inc. | 5.4% | Differentiate through long-term implantable CGM technology, aiming for extended wear time and user convenience. | Specializes in the world's first and only long-term implantable CGM system, offering up to 6 months of continuous glucose monitoring. | Received FDA approval for its Eversense E3 CGM System, extending its wear time to 6 months. | Eversense E3 CGM SystemEversense XL CGM SystemEversense Bridge |
| 3 | i-SENS | 5.1% | Offer a comprehensive range of affordable and accurate blood glucose monitoring (BGM) and CGM systems, expanding globally. | A leading Asian manufacturer of self-monitoring blood glucose systems, also expanding into continuous glucose monitoring. | Launched its CareSens Air continuous glucose monitoring system in select markets, expanding its product portfolio beyond traditional BGM. | CareSens AirCareSens N PremierCareSens H+1 |
| 4 | Nemaura Medical Inc. | 4.9% | Commercialize a non-invasive, disposable CGM patch technology that offers a cost-effective alternative for diabetes management and health monitoring. | Develops the world's first CE-marked non-invasive wearable continuous glucose monitor, sugarBEAT. | Received CE mark approval for its sugarBEAT non-invasive CGM for use in Europe. | sugarBEATproBEATNemaura Health App |
| 5 | MicroTech Medical (Hangzhou) Co., Ltd. | 4.6% | Provide integrated solutions for diabetes management, combining insulin pump therapy with continuous glucose monitoring, primarily targeting the Chinese market and emerging economies. | A prominent Chinese medical device company focusing on integrated diabetes solutions, including both insulin pumps and CGM. | Expanded its domestic market share in China with its integrated diabetes management solutions, including its Equil CGM. | Equil Patch Insulin PumpEquil Glucose Monitoring SystemEquil Blood Glucose Meter |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
DexCom, Senseonics Holdings, Inc., i-SENS, Nemaura Medical Inc., MicroTech Medical (Hangzhou) Co., Ltd., Sichuan Aikang Medical Device Co., Ltd., AgaMatrix, LLC, Movano Inc., Know Labs, Integrity Applications, Inc. (dba GlucoTrack), Afon Technology, DiaMonTech GmbH, Noviosense, Bionics Co., Ltd., Pocared Diagnostics, PharmaSens AG, Mediwise, Glucovation, Visseiro GmbH (SugaSense), Eirene Medical Inc.
The global Continuous Glucose Monitoring market features a competitive landscape led by DexCom, Senseonics Holdings, Inc., i-SENS, Nemaura Medical Inc., MicroTech Medical (Hangzhou) Co., Ltd., and Sichuan Aikang Medical Device Co., Ltd., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
DexCom
Senseonics Holdings, Inc.
i-SENS
Nemaura Medical Inc.
MicroTech Medical (Hangzhou) Co., Ltd.
Sichuan Aikang Medical Device Co., Ltd.
AgaMatrix, LLC
Movano Inc.
Know Labs
Integrity Applications, Inc. (dba GlucoTrack)
Afon Technology
DiaMonTech GmbH
Noviosense
Bionics Co., Ltd.
Pocared Diagnostics
PharmaSens AG
Mediwise
Glucovation
Visseiro GmbH (SugaSense)
Eirene Medical Inc.
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Major CGM Manufacturer Launches Next-Gen Sensor with Enhanced Connectivity
A leading continuous glucose monitoring (CGM) device manufacturer has unveiled its latest sensor, featuring significantly improved Bluetooth range and direct integration with smartwatches and digital health platforms. This launch aims to provide users with more seamless data access and management capabilities.
CGM Provider Expands Global Access with New Distribution Partnerships
A prominent CGM company has announced strategic partnerships with major pharmaceutical distributors and healthcare providers across several emerging markets in Asia and Latin America. This expansion is set to significantly broaden patient access to glucose monitoring technology in previously underserved regions.
Digital Health Giant Acquires AI-Powered CGM Analytics Platform
A global digital health and wellness conglomerate has completed the acquisition of a specialized AI-driven platform that provides predictive insights and personalized recommendations from CGM data. This move signals a strong push towards integrating advanced analytics into diabetes management solutions.
CGM Leader Partners with Telehealth Provider for Integrated Diabetes Care
A top-tier continuous glucose monitoring manufacturer has forged a strategic partnership with a national telehealth provider to offer comprehensive virtual diabetes management programs. This collaboration aims to combine real-time glucose data with remote medical consultations, improving patient outcomes and convenience.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $7.5 Bn |
| Market Size (Forecast) | $18.8 Bn |
| CAGR | 9.6% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 24 Countries |
| Segments Covered | 6 Segments, 20 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included